Aldeyra Therapeutics shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Aldeyra Therapeutics (ALDX) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Aldeyra Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aldeyra Therapeutics held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aldeyra Therapeutics by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $4.6k | 892 | 5.18 |
| 2023-09-30 | $75k | 11k | 6.68 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas